Azenta, Inc. (NASDAQ:AZTA) Shares Sold by HM Payson & Co.

HM Payson & Co. lessened its stake in Azenta, Inc. (NASDAQ:AZTA) by 9.4% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 30,267 shares of the company’s stock after selling 3,129 shares during the quarter. HM Payson & Co.’s holdings in Azenta were worth $1,824,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in AZTA. Park Avenue Securities LLC raised its stake in shares of Azenta by 1.6% in the 1st quarter. Park Avenue Securities LLC now owns 12,181 shares of the company’s stock valued at $734,000 after acquiring an additional 192 shares during the period. Envestnet Portfolio Solutions Inc. raised its stake in shares of Azenta by 1.7% in the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 13,488 shares of the company’s stock valued at $813,000 after acquiring an additional 229 shares during the period. Retirement Systems of Alabama raised its stake in shares of Azenta by 0.3% in the 4th quarter. Retirement Systems of Alabama now owns 75,339 shares of the company’s stock valued at $4,908,000 after acquiring an additional 230 shares during the period. Headlands Technologies LLC raised its stake in shares of Azenta by 35.6% in the 4th quarter. Headlands Technologies LLC now owns 883 shares of the company’s stock valued at $58,000 after acquiring an additional 232 shares during the period. Finally, Raymond James & Associates raised its stake in shares of Azenta by 0.3% in the 4th quarter. Raymond James & Associates now owns 96,126 shares of the company’s stock valued at $6,262,000 after acquiring an additional 285 shares during the period. Institutional investors and hedge funds own 99.08% of the company’s stock.

Wall Street Analysts Forecast Growth

AZTA has been the topic of several analyst reports. Evercore ISI lifted their price target on shares of Azenta from $52.00 to $53.00 and gave the stock an “in-line” rating in a research note on Tuesday, July 2nd. Needham & Company LLC dropped their price target on shares of Azenta from $75.00 to $69.00 and set a “buy” rating on the stock in a research note on Thursday, May 9th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $67.00.

Azenta Price Performance

Azenta stock traded down $3.12 during midday trading on Friday, hitting $56.74. 473,569 shares of the stock were exchanged, compared to its average volume of 440,684. Azenta, Inc. has a 1 year low of $44.00 and a 1 year high of $69.16. The firm has a market cap of $3.06 billion, a P/E ratio of -20.94 and a beta of 1.51. The company has a 50 day moving average price of $54.49 and a two-hundred day moving average price of $57.68.

Azenta (NASDAQ:AZTA) last announced its quarterly earnings data on Wednesday, May 8th. The company reported $0.05 earnings per share for the quarter, topping the consensus estimate of $0.02 by $0.03. The company had revenue of $159.13 million during the quarter, compared to analyst estimates of $159.89 million. Azenta had a negative net margin of 23.12% and a positive return on equity of 0.81%. The firm’s revenue for the quarter was up 7.2% compared to the same quarter last year. During the same period last year, the business earned ($0.06) EPS. As a group, analysts predict that Azenta, Inc. will post 0.28 EPS for the current year.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.